Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.
Cancer Chemotherapy and Pharmacology.
Times cited: 13
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
Clinical Cancer Research.
Times cited: 171
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge conference assessing opportunities for combination therapy.
Journal of Thoracic Oncology.
Times cited: 8